St. Gancher et al., APOMORPHINE INFUSIONAL THERAPY IN PARKINSONS-DISEASE - CLINICAL UTILITY AND LACK OF TOLERANCE, Movement disorders, 10(1), 1995, pp. 37-43
We assessed the clinical utility of apomorphine infusional therapy in
patients with parkinsonism and motor fluctuations and sought evidence
for alterations in drug response resulting from chronic treatment. Six
patients with Parkinson's disease were treated for 3 months with s.c,
infusions of apomorphine administered during waking hours. At the beg
inning and the end of the study, test doses of apomorphine (12.5-100 m
u g/kg) were administered to establish a dose-response curve. Over the
study, the patients reported a significant improvement in the number
of ''on'' hours experienced per day and substantially reduced the dose
and frequency of levodopa and other antiparkinsonian medications. No
average change in apomorphine dose-response relationships or pharmacok
inetics was observed during the study, However, two patients lowered t
he infusion rate during the 3-month observation and exhibited higher d
rug levels and longer responses following test doses of apomorphine gi
ven at the end of the study. Although pragmatic concerns with the use
of infusion pumps solutions and adverse effects limited the overall be
nefit afforded by the treatment, this kind of drug treatment may be us
eful in selected patients with severe parkinsonism and fluctuations.